InBody continues to work closely with academic researchers on a global scale to develop more in-depth clinical applications of body composition. With our long history in the industry, we provide more than 7,000 research publications.
Use the search box below to find key terms in research papers. For category-specific or recommended results, use the dropdown lists provided.
Research title with ★ indicates InBody recommended paper.
Amelioration of fatty liver index in patients with type 2 diabetes on ipragliflozin: an association with glucose-lowering effec
Endocrinology
Author
Takase T et al.
liver disease in the both Western and oriental countries [1, 2]. NAFLD and type 2 diabetes frequently
coex- ist, sharing pathogenetic requisites such as obesity, insulin resistance. Indeed, NAFLD
is highly prevalent (49.6–74%) among patients with type 2 diabetes [3]. Moreover, the presence
of type 2 diabetes is a risk fac- tor not only for the development of nonalcoholic ste- atohepatitis
(NASH), but also for the development of cirrhosis and hepatocellular carcinoma in patients with …
Full text
